Purpose-led, Performance-driven

DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.

At a glance

Key facts and figures about DSM, our broad, global nutrition business and focused, high-quality, specialty materials portfolio and our people, planet & profit performance.

Results center

Annual Results published on 16 February confirm DSM delivered a solid financial performance in 2020 and achieved key milestones in the first full year of its Strategy 2021.

Share center

In 2019 DSM celebrated the 30th anniversary of its privatisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Headlines (continuing operations) 2020


Net sales

€7,998 in 2019


Adjusted EBITDA

€1,551 in 2019


Adjusted EBITDA margin

19.4% in 2019


Our Nutrition cluster comprises DSM Nutritional Products, DSM Food Specialties and DSM Hydrocolloids. This cluster provides solutions for animal precision nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, personalized nutrition and personal care.

We are active at all stages of the associated value chains, producing pure active ingredients, incorporating them into sophisticated forms and providing tailored premixes, forward solutions and branded consumer products. Our unique portfolio of products and services is global and highly diversified, serving customers and other stakeholders locally across an extensive range of end-markets worldwide.


Net sales

€6,028 in 2019. >80% of group net sales


Adjusted EBITDA

€1,250 in 2019


Adjusted EBITDA margin

20.7% in 2019 & an ambition of >20%


Animal nutrition

Sales: ↑ (2019: €2,892)
Organic Growth: ↑8%
Volume Growth: ↑4%
Price Growth: ↑4%


Animal nutrition premix facilities

& 15 human nutrition premix facilities


Human nutrition

Sales: ↑ (2019: €2,046)
Organic Growth: ↑5%
Volume Growth: ↑7%
Price Growth: ↓2%


of sales

came from immunity-optimizing ingredients in 2020


Food Specialties

Sales: ↑ (2019: €572)
Sales: ↑13%
Organic Growth: ↑4%



of energy-saving enzyme solutions to the global brewing industry


Personal Care

Sales: ↓ (2019: €425)
Sales: ↓5%
Organic Growth: ↓4%


of our skin care portfolio

is > 90% natural in origin


Our Materials cluster comprises DSM Engineering Materials and DSM Protective Materials. The cluster comprises a high-quality portfolio of specialty materials for global end-markets including electrical components and electronics, automotive, food packaging, medical, personal protection, commercial marine, and apparel. Through our advanced and sustainable solutions, we are meeting demand for safer materials, greater efficiency and improved environmental performance.


Net sales

€1,744 in 2019


Adjusted EBITDA

€372 in 2019


Adjusted EBITDA margin

21.3% in 2019


Organic sales development

-9% in 2019


Engineering Materials

Sales: ↓ (2019: €1,406)
Volume Growth: ↓6%


Renewable electricity

used to manufacture materials for Apple’s products


of Engineering Materials portfolio

to contain alternatives with >25% recycled and/or bio-based content by 2030


Protective Materials

Sales: ↓ (2019: €338)
Volume Growth: ↓9%


metric ton

of bio-based Dyneema® generates < 5 tons CO2eq than fossil-based Dyneema®

Latest financial & regulatory news

Investor contacts

Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures. 

Dave Huizing

Vice President
Investor Relations
+31 45 578 2864

Sandra Segers

PA to Dave Huizing
Investor Relations
+31 45 578 2864

Anna Morello

Investor Relations
+31 45 578 2282

Marc Silvertand

Investor Relations
+31 45 578 2348

Daniel Uribe

Investor Relations
+31 45 578 2864

Petra Volk

Support Officer
Investor Relations
+31 45 578 2511

Read more

  • Key financials

    DSM's latest net sales from continuing operations, adjusted net earnings per ordinary share, balance sheet, income statement and cash flow statement

  • Factbooks

    An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.

  • Corporate Governance

    We believe in doing business the right way: from our management and supervisory boards, to our code of business conduct, to our position papers and statements on key industry issues.

This site uses cookies to optimize your user experience.

Read more